Mill Creek Capital Advisors LLC Reduces Stock Position in SPDR S&P Biotech ETF (NYSEARCA:XBI)

Mill Creek Capital Advisors LLC lowered its position in SPDR S&P Biotech ETF (NYSEARCA:XBI) by 3.1% during the fourth quarter, HoldingsChannel.com reports. The fund owned 6,767 shares of the exchange traded fund’s stock after selling 218 shares during the quarter. Mill Creek Capital Advisors LLC’s holdings in SPDR S&P Biotech ETF were worth $609,000 at the end of the most recent reporting period.

Several other hedge funds have also recently bought and sold shares of XBI. Kingsview Wealth Management LLC increased its position in shares of SPDR S&P Biotech ETF by 60.3% in the fourth quarter. Kingsview Wealth Management LLC now owns 6,350 shares of the exchange traded fund’s stock valued at $572,000 after buying an additional 2,388 shares in the last quarter. Clientfirst Wealth Management LLC acquired a new position in SPDR S&P Biotech ETF during the fourth quarter worth about $284,000. Golden State Wealth Management LLC purchased a new stake in shares of SPDR S&P Biotech ETF in the fourth quarter valued at about $29,000. Strategic Financial Concepts LLC purchased a new position in shares of SPDR S&P Biotech ETF during the 4th quarter worth approximately $2,447,000. Finally, Telos Capital Management Inc. lifted its stake in SPDR S&P Biotech ETF by 6.6% in the 4th quarter. Telos Capital Management Inc. now owns 27,816 shares of the exchange traded fund’s stock valued at $2,505,000 after buying an additional 1,710 shares in the last quarter.

SPDR S&P Biotech ETF Stock Performance

SPDR S&P Biotech ETF stock opened at $90.34 on Tuesday. SPDR S&P Biotech ETF has a fifty-two week low of $81.14 and a fifty-two week high of $105.47. The company has a market capitalization of $6.89 billion, a price-to-earnings ratio of 11.47 and a beta of 1.11. The stock has a fifty day moving average of $92.40 and a two-hundred day moving average of $96.38.

About SPDR S&P Biotech ETF

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.